H

Hugel Inc
KOSDAQ:145020

Watchlist Manager
Hugel Inc
KOSDAQ:145020
Watchlist
Price: 258 500 KRW -1.15% Market Closed
Market Cap: 3.3T KRW

Hugel Inc
Investor Relations

In the bustling landscape of the global biopharmaceutical market, Hugel Inc. stands out as a formidable player rooted in the dynamic world of aesthetics and medical treatments. Established in South Korea, Hugel Inc. embarked on its journey with a focus on producing botulinum toxin products, a niche that has rapidly expanded due to a surge in demand for non-surgical cosmetic procedures. The company navigated early challenges with innovative prowess, crafting a strong reputation for high-quality products that cater to a global clientele. The ethos of innovation and safety permeates its operations, enabling Hugel to diversify its portfolio and steadily gain traction in international markets, including significant footprints in Asia, Europe, and Latin America. Through a network of strategic partnerships and a robust distribution channel, Hugel not only pioneered advancements in cosmetic treatments but also cemented its status as a key contributor to the evolving aesthetics industry.

The company's revenue model hinges upon the development, production, and distribution of its botulinum toxin and hyaluronic acid-based products. By focusing on research and development, Hugel enhances its capacity to innovate, delivering cutting-edge solutions that meet the rising demands of beauty-conscious consumers. Its business strategy also extends to therapeutics, exploring potential applications of its core products to address various medical conditions. Hugel's financial growth is propelled by the continuous expansion into new geographical territories and the gradual introduction of new, clinically-researched products. As the company continues to navigate the intricate regulatory landscapes of the pharmaceutical industry, it maintains an unwavering commitment to quality, ensuring that each product meets rigorous safety standards while catering to the evolving desires of its diverse customer base worldwide.

Show more
Loading

Earnings Calls

No Earnings Calls Available

Management

Mr. Ji-hoon Sohn
CEO & Executive Director
No Bio Available
J. T. Kim
MD & CFO
No Bio Available
Seonho Han
VP and Chief Sales & Marketing Officer
No Bio Available
Mr. Soon-Woo Kwon
VP & Chief Production Officer
No Bio Available
Jennifer Rho
MD & Chief Strategy Officer
No Bio Available
Minjong Kang
MD & Head of Marketing
No Bio Available
Jihye Song
MD & Head of Cosmetics
No Bio Available
Young Mahn Yoo
MD & Chief Production Officer
No Bio Available

Contacts

Address
GANGWON-DO
Chuncheon
61-20, Sinbuk-ro, Sinbuk-eup
Contacts
+82338155200
www.hugel.co.kr